Investor Stock List
Ranked #7,237 of 8,699 institutional investors

B Group, Inc.

Dallas, TX

$143M
US stock portfolio at live prices · today −$3.0M (−2.07%)
Market closed. Prices as of Nov 20, 7:11 AM ET
Value at quarter end (Q3 2026)
$162M
Change from Q2 2026
−$14.1M (−7.98%)
Positions
19 · 1 new, 0 sold out
Filed
Nov 16, 2026

Holdings

Q3 2026 13F, live prices
ADMA 30.4%NRXP 7.63%PALI 7.39%PRAX 7.23%SGHT 7.21%
StockSharesValue, live% of portfoliovs Q2 2026
ADMA ADMA Biologics, Inc.3,262,542$43.5M30.4%Unchanged
NRXP NRx Pharmaceuticals, Inc.4,277,200$10.9M7.63%Added +5%
PALI Palisade Bio, Inc.11,414,285$10.6M7.39%Unchanged
PRAX Praxis Precision Medicines, Inc.33,237$10.3M7.23%Unchanged
SGHT Sight Sciences, Inc.970,000$10.3M7.21%Unchanged
ZLAB Zai Lab Limited450,646$9.9M6.91%Unchanged
TSHA Taysha Gene Therapies, Inc.1,800,556$6.8M4.75%Unchanged
SYRE Spyre Therapeutics, Inc.62,500$6.1M4.27%Reduced −11%
ORKA Oruka Therapeutics, Inc.55,000$5.4M3.75%Reduced −27%
AURA Aura Biosciences, Inc.764,243$5.3M3.73%Unchanged
FTH Faeth Therapeutics, Inc.610,169$5.3M3.71%Unchanged
ASMB Assembly Biosciences, Inc.175,706$4.0M2.77%Unchanged
CLLS Cellectis S.A.3,281,501$3.2M2.26%Unchanged
IOVA Iovance Biotherapeutics, Inc.425,000$3.1M2.17%Reduced −72%
GPCR Structure Therapeutics Inc.180,000$3.1M2.16%Added +29%
RARE Ultragenyx Pharmaceutical Inc.135,000$2.3M1.63%Unchanged
DRUG Bright Minds Biosciences Inc.95,000$2.0M1.38%Added +41%
QTTB Q32 Bio Inc.65,000$551K0.39%New
FHTX Foghorn Therapeutics Inc.200,000$356K0.25%Unchanged